Tissue Regenix Group PLC (AIM:TRX) has appointed its chief financial officer, Kirsten Lund, to the board with immediate effect. The regenerative medical devices company, which trades on AIM, confirmed the move following Thursday’s announcement of her appointment as CFO.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com